Corrigendum: Untargeted metabolomics identified kynurenine as a predictive prognostic biomarker in acute myocardial infarction

Xiaolin Zhang,Yi Cai,Xu Su,Quanmin Jing,Haiwei Liu,Kun Na,Miaohan Qiu,Xiaoxiang Tian,Dan Liu,Tianxiao Wu,Chenghui Yan,Yaling Han

DOI: https://doi.org/10.3389/fimmu.2023.1163419

IF: 7.3

2023-03-08

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2022.950441.].

immunology

What problem does this paper attempt to address?

Untargeted metabolomics identified kynurenine as a predictive prognostic biomarker in acute myocardial infarction (vol 13, 950441, 2022)

Xiaolin Zhang,Yi Cai,Xu Su,Quanmin Jing,Haiwei Liu,Kun Na,Miaohan Qiu,Xiaoxiang Tian,Dan Liu,Tianxiao Wu,Chenghui Yan,Yaling Han

DOI: https://doi.org/10.3389/fimmu.2023.1163419

2023-01-01

SSRN Electronic Journal

Abstract:ObjectiveThe occurrence of cardiovascular adverse events in the first year after ST-acute myocardial infarction (STEMI) remains high; therefore, identification of patients with poor prognosis is essential for early intervention. This study aimed to evaluate the prognostic value of metabolomics-based biomarkers in STEMI patients and explore their functional mechanisms. MethodsMetabolite profiling was performed using nuclear magnetic resonance. The plasma concentration of Kynurenine (Kyn) was measured using ultraperformance liquid chromatography/electrospray ionization quadruple time-of-flight mass spectrometry. Major adverse cardiac and cerebral events were assessed for 1 year. A functional metabolomics strategy was proposed for investigating the role of Kyn in both vitro and vivo models. ResultsThe adjusted hazard ratios in STEMI patients for Kyn in the 4(th) quartile 7.12(5.71-10.82) was significantly higher than that in the 3(rd) quartile 3.03(2.62-3.74), 2(nd) quartile 1.86(1.70-2.03), and 1(st) quartile 1.20(0.93-1.39).The incidence of MACCE was significantly different among Kyn quartiles and the highest incidence of MACCE was observed in the 4th quartile when compared with the 1st quartile (9.84% vs.2.85%, P<0.001).Immunofluorescence staining indicated that indoleamine-pyrrole 2,3-dioxygenase (IDO1) was located in the CD68 positive staining area of thrombi from STEMI patients and Kyn was induced in the early phase after myocardial infarction. Kyn could trigger inflammation and oxidative stress of macrophage cells by activation of the Sirt3-acSOD2/IL-1 beta signaling pathway in vitro. ConclusionsPlasma Kyn levels were positively associated with the occurrence of STEMI. Kyn could induce macrophage cells inflammation and oxidative stress by activating the Sirt3-acSOD2/IL-1 beta pathway following myocardial ischemia injury. Kyn could be a robust biomarker for STEMI prognosis and reduction of Kyn could be beneficial in STEMI patients.
Corrigendum: Utility of S100A12 as an Early Biomarker in Patients With ST-Segment Elevation Myocardial Infarction

Xiaolin Zhang,Minghui Cheng,Naijing Gao,Yi Li,Chenghui Yan,Xiaoxiang Tian,Dan Liu,Miaohan Qiu,Xiaozeng Wang,Bo Luan,Jie Deng,Shouli Wang,Hongyan Tian,Geng Wang,Xinliang Ma,Gregg W. Stone,Yaling Han

DOI: https://doi.org/10.3389/fcvm.2022.840102

IF: 3.6

2022-02-23

Frontiers in Cardiovascular Medicine

Abstract:[This corrects the article DOI: 10.3389/fcvm.2021.747511.].

cardiac & cardiovascular systems
Corrigendum: Single-cell RNA Sequencing of Peripheral Blood Mononuclear Cells from Acute Myocardial Infarction.

Jun Qian,Yanhua Gao,Yan Lai,Zi Ye,Yian Yao,Keke Ding,Jing Tong,Hao Lin,Guoqi Zhu,Yunan Yu,Haoran Ding,Deqiang Yuan,Jiapeng Chu,Fei Chen,Xuebo Liu

DOI: https://doi.org/10.3389/fimmu.2024.1462970

IF: 7.3

2024-01-01

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2022.908815.].
[Corrigendum] Exosomal microRNA‑4516, microRNA‑203 and SFRP1 are potential biomarkers of acute myocardial infarction

Peng Liu,Shuya Wang,Kaiyuan Li,Yang Yang,Yilong Man,Fengli Du,Lei Wang,Jing Tian,Guohai Su

DOI: https://doi.org/10.3892/mmr.2024.13289

Abstract:Subsequently to the publication of the above article, the authors have realized that, in Fig. 1A, the incorrect image was uploaded to show the ultrastructure of exos isolated from plasma and examined using transmission electron microscopy (essentially, the image in question had already appeared in an article published by the same research group in Journal of Cellular and Molecular Medicine). In addition, the '+' and '-' signs for the 'Cell lysis' experiments shown underneath the gels in Fig. 1B were incorporated the wrong way around. The revised version of Fig. 1, showing the correct image in Fig. 1A and the correct labels in Fig. 1B, is shown below. Note that the errors made in assembling this figure did not have a major impact on either the results or the conclusions reported in this paper. The authors are grateful to the Editor of Molecular Medicine Reports for allowing them this opportunity to publish a corrigendum, and apologize to the readership of the Journal for any inconvenience caused. [Molecular Medicine Reports 27: 124, 2023; DOI: 10.3892/mmr.2023.13010].
Corrigendum: Honokiol ameliorates post-myocardial infarction heart failure through Ucp3-mediated reactive oxygen species inhibition

Jianyu Liu,Minghai Tang,Tao Li,Zhengying Su,Zejiang Zhu,Caixia Dou,Yan Liu,Heying Pei,Jianhong Yang,Haoyu Ye,Lijuan Chen

DOI: https://doi.org/10.3389/fphar.2022.1000887

IF: 5.6

2022-09-27

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2022.811682.].

pharmacology & pharmacy
Corrigendum: Liquid chromatograph-mass spectrometry-based non-targeted metabolomics discovery of potential endogenous biomarkers associated with prostatitis rats to reveal the effects of magnoflorine

Yin Yuan,Fei-Xue Dong,Xu Liu,Hong-Bin Xiao,Zhong-Guang Zhou

DOI: https://doi.org/10.3389/fphar.2022.1034753

IF: 5.6

2022-10-12

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2021.741378.].

pharmacology & pharmacy
Corrigendum: Bibliometric and Visual Analysis on Metabolomics in Coronary Artery Disease Research

Ning Yu,Ruirui Wang,Baocheng Liu,Lei Zhang

DOI: https://doi.org/10.3389/fcvm.2022.937508

IF: 3.6

2022-06-28

Frontiers in Cardiovascular Medicine

Abstract:[This corrects the article DOI: 10.3389/fcvm.2022.804463.].

cardiac & cardiovascular systems
Corrigendum: Identification and validation of immune-related methylation clusters for predicting immune activity and prognosis in breast cancer

Anli Yang,Ying Zhou,Yanan Kong,Xiaoli Wei,Feng Ye,Lijuan Zhang,Xian Zhong,Mingyue Li,Shilin Lu,Xin An,Weikai Xiao

DOI: https://doi.org/10.3389/fimmu.2024.1372991

IF: 7.3

2024-01-31

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2021.704557.].

immunology
Corrigendum: Integrated metabolomics and proteomics reveal biomarkers associated with hemodialysis in end-stage kidney disease

Weiwei Lin,Fatemeh Mousavi,Benjamin C. Blum,Christian F Heckendorf,Jarrod Moore,Noah Lampl,Mark McComb,Sergei Kotelnikov,Wenqing Yin,Nabil Rabhi,Matthew D. Layne,Dima Kozakov,Vipul C. Chitalia,Andrew Emili

DOI: https://doi.org/10.3389/fphar.2024.1376058

IF: 5.6

2024-02-10

Frontiers in Pharmacology

Abstract:This article is a correction to: Integrated metabolomics and proteomics reveal biomarkers associated with hemodialysis in end-stage kidney disease

pharmacology & pharmacy
Corrigendum: Identification and validation of a novel senescence-related biomarker for thyroid cancer to predict the prognosis and immunotherapy

Yangyang Guo,Kenan Cen,Qiaoqiao Chen,Ying Dai,Yifeng Mai,Kai Hong

DOI: https://doi.org/10.3389/fimmu.2023.1229541

IF: 7.3

2023-06-05

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2023.1128390.].

immunology
Corrigendum: A New Prognostic Risk Score: Based on the Analysis of Autophagy-Related Genes and Renal Cell Carcinoma

Minxin He,Mingrui Li,Yawen Guan,Ziyan Wan,Jie Tian,Fangshi Xu,Haibin Zhou,Mengchun Gao,Hang Bi,Tie Chong

DOI: https://doi.org/10.3389/fgene.2022.904512

IF: 3.7

2022-01-01

Frontiers in Genetics

Abstract:[This corrects the article DOI: 10.3389/fgene.2021.820154.].
Corrigendum: Impact of Serum Uric Acid Lowering and Contemporary Uric Acid-Lowering Therapies on Cardiovascular Outcomes: A Systematic Review and Meta-Analysis.

Hangying Ying,Hongdi Yuan,Xiaomei Tang,Wenpu Guo,Ruhong Jiang,Chenyang Jiang

DOI: https://doi.org/10.3389/fcvm.2021.723626

IF: 3.6

2021-01-01

Frontiers in Cardiovascular Medicine

Abstract:[This corrects the article DOI: 10.3389/fcvm.2021.641062.].
Corrigendum: Predictive value of intratumoral-metabolic heterogeneity derived from 18F-FDG PET/CT in distinguishing microsatellite instability status of colorectal carcinoma

Li Zhang,Yu Liu,Ying Ding,Yinqian Deng,Huanyu Chen,Fan Hu,Jun Fan,Xiaoli Lan,Wei Cao

DOI: https://doi.org/10.3389/fonc.2023.1351842

IF: 4.7

2024-01-05

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2023.1065744.].

oncology
Corrigendum: Identification of Hypoxia Induced Metabolism Associated Genes in Pulmonary Hypertension

Yang-Yang He,Xin-Mei Xie,Hong-Da Zhang,Jue Ye,Selin Gencer,Emiel P. C. van der Vorst,Yvonne Döring,Christian Weber,Xiao-Bin Pang,Zhi-Cheng Jing,Yi Yan,Zhi-Yan Han

DOI: https://doi.org/10.3389/fphar.2021.810178

IF: 5.6

2021-12-15

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2021.753727.].

pharmacology & pharmacy
Corrigendum: Metabolomic analysis in spondyloarthritis: A systematic review

Tianwen Huang,Yaoyu Pu,Xiangpeng Wang,Yanhong Li,Hang Yang,Yubin Luo,Yi Liu

DOI: https://doi.org/10.3389/fmicb.2022.1100290

IF: 5.2

2022-12-12

Frontiers in Microbiology

Abstract:[This corrects the article DOI: 10.3389/fmicb.2022.965709.].

microbiology
Corrigendum: Development and validation of a m6A -regulated prognostic signature in lung adenocarcinoma

Yaxin Chen,Lei Xia,Yuxuan Peng,Gang Wang,Liyun Bi,Xue Xiao,Cui Li,Weimin Li

DOI: https://doi.org/10.3389/fonc.2023.1309950

IF: 4.7

2023-11-07

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2022.947808.].

oncology
Corrigendum: Identification and Validation of Novel Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma

Xiaofan Hu,Mingyang Bao,Jiacheng Huang,Lin Zhou,Shusen Zheng

DOI: https://doi.org/10.3389/fonc.2020.617539

IF: 4.7

2020-01-01

Frontiers in Oncology

Abstract:CORRECTION article Front. Oncol., 20 November 2020Sec. Molecular and Cellular Oncology Volume 10 - 2020 | https://doi.org/10.3389/fonc.2020.617539
Corrigendum: Clinical Significance and Immunometabolism Landscapes of a Novel Recurrence-Associated Lipid Metabolism Signature In Early-Stage Lung Adenocarcinoma: A Comprehensive Analysis

Mingchuang Zhu,Qingpeng Zeng,Tao Fan,Yuanyuan Lei,Feng Wang,Sufei Zheng,Xinfeng Wang,Hui Zeng,Fengwei Tan,Nan Sun,Qi Xue,Jie He

DOI: https://doi.org/10.3389/fimmu.2022.909105

IF: 7.3

2022-05-04

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2022.783495.].

immunology
Corrigendum: Transmembrane and coiled-coil domains 3 is a diagnostic biomarker for predicting immune checkpoint blockade efficacy in hepatocellular carcinoma

Xinyao Hu,Hua Zhu,Shi Feng,Chaoqun Wang,Yingze Ye,Xiaoxing Xiong

DOI: https://doi.org/10.3389/fgene.2022.1117731

IF: 3.7

2023-01-16

Frontiers in Genetics

Abstract:[This corrects the article DOI: 10.3389/fgene.2022.1006357.].

genetics & heredity
Corrigendum: NPM1 Is a Prognostic Biomarker Involved in Immune Infiltration of Lung Adenocarcinoma and Associated With m6A Modification and Glycolysis

Xu-Sheng Liu,Lu-Meng Zhou,Ling-Ling Yuan,Yan Gao,Xue-Yan Kui,Xiao-Yu Liu,Zhi-Jun Pei

DOI: https://doi.org/10.3389/fimmu.2021.751004

IF: 7.3

2021-08-31

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2021.724741.].

immunology

Corrigendum: Untargeted metabolomics identified kynurenine as a predictive prognostic biomarker in acute myocardial infarction

Untargeted metabolomics identified kynurenine as a predictive prognostic biomarker in acute myocardial infarction (vol 13, 950441, 2022)

Corrigendum: Utility of S100A12 as an Early Biomarker in Patients With ST-Segment Elevation Myocardial Infarction

Corrigendum: Single-cell RNA Sequencing of Peripheral Blood Mononuclear Cells from Acute Myocardial Infarction.

[Corrigendum] Exosomal microRNA‑4516, microRNA‑203 and SFRP1 are potential biomarkers of acute myocardial infarction

Corrigendum: Honokiol ameliorates post-myocardial infarction heart failure through Ucp3-mediated reactive oxygen species inhibition

Corrigendum: Liquid chromatograph-mass spectrometry-based non-targeted metabolomics discovery of potential endogenous biomarkers associated with prostatitis rats to reveal the effects of magnoflorine

Corrigendum: Bibliometric and Visual Analysis on Metabolomics in Coronary Artery Disease Research

Corrigendum: Identification and validation of immune-related methylation clusters for predicting immune activity and prognosis in breast cancer

Corrigendum: Integrated metabolomics and proteomics reveal biomarkers associated with hemodialysis in end-stage kidney disease

Corrigendum: Identification and validation of a novel senescence-related biomarker for thyroid cancer to predict the prognosis and immunotherapy

Corrigendum: A New Prognostic Risk Score: Based on the Analysis of Autophagy-Related Genes and Renal Cell Carcinoma

Corrigendum: Impact of Serum Uric Acid Lowering and Contemporary Uric Acid-Lowering Therapies on Cardiovascular Outcomes: A Systematic Review and Meta-Analysis.

Corrigendum: Predictive value of intratumoral-metabolic heterogeneity derived from 18F-FDG PET/CT in distinguishing microsatellite instability status of colorectal carcinoma

Corrigendum: Identification of Hypoxia Induced Metabolism Associated Genes in Pulmonary Hypertension

Corrigendum: Metabolomic analysis in spondyloarthritis: A systematic review

Corrigendum: Development and validation of a m6A -regulated prognostic signature in lung adenocarcinoma

Corrigendum: Identification and Validation of Novel Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma

Corrigendum: Clinical Significance and Immunometabolism Landscapes of a Novel Recurrence-Associated Lipid Metabolism Signature In Early-Stage Lung Adenocarcinoma: A Comprehensive Analysis

Corrigendum: Transmembrane and coiled-coil domains 3 is a diagnostic biomarker for predicting immune checkpoint blockade efficacy in hepatocellular carcinoma

Corrigendum: NPM1 Is a Prognostic Biomarker Involved in Immune Infiltration of Lung Adenocarcinoma and Associated With m6A Modification and Glycolysis